How many companies will be left standing once consolidation hits the AI in healthcare sector? Which pharma companies are ...

Pfizer claims Metsera breached their merger agreement, adding that a tie-up of the biotech with GLP-1 drug giant Novo Nordisk ...

With federal PBM reform stalled, states like California are stepping up with laws like SB 41 to boost transparency and lower ...

In a Monday letter, a group of 350 organizations urged Congress to make Covid-19 Medicare telehealth flexibilities permanent. If Congress can’t make these flexibilities —which are set to expire in ...

Function Health, a membership-based platform that gives consumers access to more than 100 different lab tests, on Tuesday announced the close of a sizable funding round — one that includes about a ...

In the rare disease hereditary angioedema, or HAE, painful swelling attacks can happen anywhere in the body without warning. Drugs are available for acute treatment of these attacks, but they’re all ...

Elektra Health, a digital health company for women going through menopause, has secured $3.3 million in extended seed funding, which it will use to expand its care to more patients, it announced ...

Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to ...

Each year, the HLTH conference gives healthcare leaders a chance to gather and share ideas. The event also gives companies the chance to announce news — oftentimes about new products, partnerships and ...

The pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission (FTC) released its second interim staff report on prescription drug middlemen. The ...

Is Risant Health the rising star of scalable, profitable value-based care models for health systems? It’s a little early to break out the champagne and toast to the company’s success, but it might ...

For a certain hormone deficiency inadequately managed with calcium and vitamin supplements, the only FDA-approved therapy is a daily injection that’s in limited supply and is set to exit the market ...